机构地区:[1]广东省中山市博爱医院生殖中心,中山528400
出 处:《生殖医学杂志》2010年第5期385-390,共6页Journal of Reproductive Medicine
基 金:广东省医学科研基金资助项目2006A165
摘 要:目的探讨性激素结合球蛋白(SHBG)检测在评价治疗多囊卵巢综合征(PCOS)不育患者中的意义。方法将533例PCOS不育患者按体重指数(BMI)分为非肥胖组(424例)和肥胖组(109例)并再按是否存在胰岛素抵抗(IR)分为四组。A组:非肥胖无IR组(162例)、B组:非肥胖IR组(262例)、C组:肥胖无IR组(42例)、D组:肥胖IR组(67例)。测定黄体生成素(LH)、卵泡刺激素(FSH)、雌二醇(E_2)、总睾酮(T)、泌乳素(PRL)、SHBG、血糖(FBG)和胰岛素(FINS)水平,计算游离雄激素指数(FAI)及稳态模型指数(HOMA-IR)。A组、C组予达英-35;B组、D组予达英-35+盐酸二甲双胍,均治疗3月后复查各指标。停药后给予枸橼酸氯米芬(克罗米芬,CC)+人绝经期促性腺激素(HMG)促排卵治疗。比较各组排卵及妊娠情况。结果四组治疗后FAI均较治疗前降低,SHBG较治疗前升高差异有显著性;四组治疗后LH、LH/FSH比值、T较治疗前降低差异有显著性;但A组HOMA-IR、FINS较治疗前升高差异有显著性,B、D组HOMA-IR、FINS较治疗前降低差异有显著性。促排卵结果显示治疗后排卵率非肥胖组高于肥胖组(85.60%vs 68.69%,P<0.01),两组治疗后有排卵患者SHBG较无排卵患者升高,FAI较无排卵患者降低;非肥胖组LH、LH/FSH比值、FINS降低(P<0.05),而肥胖组FINS、HOMA-IR则降低(P<0.05)。妊娠结局比较:非肥胖组和肥胖组妊娠分娩患者治疗后T、FAI、FINS、HOMA-IR较自然流产患者降低,SHBG升高(P<0.05);此外肥胖组妊娠分娩患者治疗后BMI较自然流产患者降低。结论无论肥胖还是非肥胖的PCOS患者,无论是否存在胰岛素抵抗,SHBG及FAI均可作为评价治疗是否有效的指标之一,可提示促排卵治疗及妊娠结局。因此在PCOS患者治疗中检测SHBG及FAI能指导临床用药,降低流产率,对优生优育有重要指导意义。Objective : To explore the significance of sex hormone-binding globulin examination in the treatment of women with polycystic ovarian syndrome (PCOS). Methods: The data of body mass index (BMI), serum levels of basal sexual hormones, sex hormone- binding globulin (SHBG), fasting blood glucose (FBG) and fasting insulin (FINS) were collected from 533 women with PCOS, aged 20-39 years. The patients were divided into four groups according to BMI and homeostasis model assessment of insulin status (HOMA-IR) : group A (non-obese without insulin resistance, n=162), group B (non-obese with insulin resistance, n=262), group C (obese without insulin resistance, n=42) and group D (obese with insulin resistance, n:67). Patients in group A and B took Diane-35 alone, while those in group C and D took Diane-35 plus metformin (1000 mg daily) for 3 months. Then clomiphene citrate (CC) and human menopausal gonadotropin (HMG) were administered to induce ovulation. The ovulation rate and pregnancy outcomes were compared among groups. Results: Free androgen index (FAI) decreased significantly and SHBG levels increased significantly in all groups after treatment. A significant decrease in serum LH levels, LH/FSH ratio and testosterone (T) levels was also found in all 4 groups after treatment (P〈0.05). FINS and HOMA-IR increased significantly A+ B) was higher than that in obese group (C-t-D) (85.60% vs. 68.69%, P〈0.01). Compared with those in non-ovulation patients, SHBG levels increased significantly in the ovulation patients after treatment in both obese and non-obese groups. In the separate analysis of those ovulated, serum levels of LH, FINS, LH/FSH ratio and FAI decreased significantly in non-obese group, while FINS, HOMA-IR decreased significantly in obese group after treatment. The serum levels of SHBG, T, FINS, FAI and HOMA-IR after treatment were significantly higher in the patients with live birth than in those with spontaneous aborti
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...